Clipping of news on Brazilian Culture, Law and Citizenship
08/06/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
August 3, 2012
The National Health Surveillance Agency (ANVISA) has determined, on Friday (3/8) in the Official Gazette, the suspension of the distribution, sale and use of the product batch 120166663 CPHD-Sodium Bicarbonate 8.4% brand Fresenius Medical Care. The product manufactured by Fresenius Medical Care Ltd. was suspended for having unsatisfactory result in testing aspect.
The suspension will last the time needed for the regularization of products with ANVISA and is effective immediately upon publication in the Official Gazette of the measure. People who have already purchased the product should discontinue use.
Check out the resolution
Source: ANVISA
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.